Indication
Combined Pulmonary Fibrosis and Emphysema
2 clinical trials
1 product
Product
TreprostinilClinical trial
An Open-Label Extension Study of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung DiseaseStatus: Terminated, Estimated PCD: 2021-08-01